Previous studies have demonstrated a link between high TOPK expression and poor clinical outcomes in different types of cancer, and that TOPK is expressed at low levels in most normal tissues (Rhodes et al, 2007; Lei et al, 2013, 2015; Park et al, 2014; Xiao et al, 2015; Ohashi et al, 2017). The gene discussed is PBK; the disease is cancer.